EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improvement in sequelae of chronic liver disease in patients with Alagille syndrome treated with maralixibat

Tin Bo Nicholas Lam iD, Maria Paulina Ordonez, Amber Hidlreth

JPGN Reports · 12.11.2026

DOI: 10.1002/jpr3.70262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JPGN Reports, online erschienen am 12.11.2026. Verfasst von Tin Bo Nicholas Lam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition University of California San Diego School of Medicine La Jolla Cali…. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maralixibat (MRX) is an orally administered, small‐molecule ileal bile acid transporter (IBAT) inhibitor used in the treatment of cholestatic pruritus in conditions such as Alagille syndrome (ALGS). MRX's beneficial effects on cholestatic pruritus are well described, however its effects on patients’ clinical manifestations of hepatic disease are less well known. We report two cases of patients with ALGS treated with MRX who demonstrated stabilization of their esophageal varices and xanthomas, respectively. Our findings demonstrate the potential role of MRX in improving the extrahepatic manifestations of liver disease in patients with ALGS. Further studies are needed to understand the physiologic mechanisms driving these changes.

Schlagwörter

Stichwörter der Autor:innen

cholestasisileal bile acid absorption transporter inhibitorvaricesxanthomas

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition University of California San Diego School of Medicine La Jolla California USA.

ORCID-Profile: Tin Bo Nicholas Lam

Zitieren

APA

Lam, T. B. N., Ordonez, M. P., & Hidlreth, A. (2026). Improvement in sequelae of chronic liver disease in patients with Alagille syndrome treated with maralixibat. JPGN Reports. https://doi.org/10.1002/jpr3.70262

Vancouver

Lam TBN, Ordonez MP, Hidlreth A. Improvement in sequelae of chronic liver disease in patients with Alagille syndrome treated with maralixibat. JPGN Reports. 2026. doi:10.1002/jpr3.70262

BibTeX
@article{Lam2026,
  author = {Lam, Tin Bo Nicholas and Ordonez, Maria Paulina and Hidlreth, Amber},
  title = {Improvement in sequelae of chronic liver disease in patients with Alagille syndrome treated with maralixibat},
  journal = {JPGN Reports},
  year = {2026},
  doi = {10.1002/jpr3.70262}
}
Kostenlos starten →